Literature DB >> 3537130

Recognition of the beta-2 microglobulin-B molecule by a CTL clone.

M E Kurtz, D Martin-Morgan, R J Graff.   

Abstract

In this report we offer evidence that the beta-2 microglobulin-B (beta 2M-B) molecule is recognized by a cytotoxic T lymphocyte (CTL). Production of GA5, a CTL clone reactive against a membrane antigen with the same strain distribution pattern as beta 2M-B, is described. This clone lysed syngeneic target cells in which native beta 2M-A molecules had been exchanged with beta 2M-B molecules by incubating the cells in serum from beta 2M-B-positive mouse strains. Conversely, the CTL clone GA5 failed to lyse its specific target when beta 2M-B molecules had been exchanged with beta 2M-A molecules by incubating the cells in serum from beta 2M-A-positive, beta 2M-B-negative mouse strains. Strain combinations were chosen so as to limit reactivity to beta 2M and to preclude reactivity to H-3 antigens, thus indicating CTL clone GA5 to be reacting specifically with beta 2M-B.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3537130

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Additional mapping of mouse chromosome 2 genes.

Authors:  R J Graff; M E Kurtz; R Paul; D Martin; D C Roopenian
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Multiplicity of chromosome 2 histocompatibility genes: new loci, H-44 and H-45.

Authors:  R J Graff; D Martin-Morgan; M E Kurtz
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  An HLA-A2 population variant with structural polymorphism in the alpha 3 region.

Authors:  R Castaño; A Ezquerra; N Doménech; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  Unexpected beta2-microglobulin sequence diversity in individual rainbow trout.

Authors:  B P Shum; K Azumi; S Zhang; S R Kehrer; R L Raison; H W Detrich; P Parham
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.